Additionally, NINJ1 is overexpressed in various cancers, such as hepatocellular carcinoma (49), acute lymphoblastic B-cell leukemia (48), urothelial bladder cancer (66), and circulating prostate cancer cells (67). Here, NINJ1 is linked to hepatocellular carcinoma.